文献速递技术与安全神经腹部PET

FDG PET 上脑低摄取合并肝高摄取与心血管危险因素相关

Concurrent Low Brain and High Liver Uptake on FDG PET Are Associated with Cardiovascular Risk Factors.
PubMed 文献 · Korean J Radiol · 2017-02-07

回顾性分析264例接受健康体检男性的FDG PET/CT,空腹血糖和糖化血红蛋白是脑低摄取的最强预测因子,腰围和γ-谷氨酰转肽酶是肝高摄取的最强预测因子;11例(4.2%)表现为脑低摄取合并肝高摄取,其中90.9%患有代谢综合征,且该组多项心血管危险因素均高于无此表现者。

要点

  • 脑低摄取合并肝高摄取在健康体检男性中占4.2%,其中90.9%患有代谢综合征。
  • 脑低摄取的最强预测因子为空腹血糖(OR=1.063)和糖化血红蛋白(OR=3.634)。
  • 肝高摄取的最强预测因子为腰围(OR=1.200)和γ-谷氨酰转肽酶(OR=1.012)。

核心结论

  • FDG PET上脑低摄取合并肝高摄取与代谢综合征密切相关,且具有该表现者的多项心血管危险因素数值高于无该表现者。

研究设计与样本

  • 回顾性研究,纳入264例接受健康体检的连续男性,空腹过夜后当日采血检测实验室指标并完成FDG PET/CT扫描;由手工放置于半卵圆中心层面额叶皮质和肝右叶实质的感兴趣区分别测量脑和肝的最大标准化摄取值。

关键影像表现/征象

  • 脑低摄取表现为半卵圆中心层面额叶皮质FDG摄取减低,肝高摄取表现为肝右叶实质FDG摄取增高。
  • 11例(4.2%)受试者同时出现脑低摄取和肝高摄取,其中除1例外(90.9%)均患有代谢综合征。

诊断标准与关键数值

  • 脑低摄取的最强预测因子为空腹血糖(OR=1.063,p<0.001)和糖化血红蛋白(OR=3.634,p=0.010)。
  • 肝高摄取的最强预测因子为腰围(OR=1.200,p<0.001)和γ-谷氨酰转肽酶(OR=1.012,p=0.001)。
  • 具有脑低摄取合并肝高摄取表现者的收缩压、腰围、空腹血糖、甘油三酯、丙氨酸氨基转移酶、胰岛素抵抗(以稳态模型评估测量)、胰岛素、糖化血红蛋白和体重指数均高于无该表现者(均p<0.001)。

临床应用与阅片要点

  • 阅片时若发现脑FDG摄取减低同时肝FDG摄取增高,应结合空腹血糖、糖化血红蛋白、腰围、γ-谷氨酰转肽酶等指标评估代谢综合征及心血管危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Concurrent low brain and high liver uptake are sometimes observed on fluorine-18-labeled fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET). We investigated the potential clinical significance of this uptake pattern related to metabolic syndrome (MS).

MATERIALS AND METHODS: We retrospectively reviewed data from 264 consecutive males who had undergone general health check-ups, including FDG PET/CT scans. After an overnight fast, the men had their peripheral blood drawn and the levels of various laboratory parameters measured; an FDG PET/CT scan was performed on the same day. We measured the maximum standardized uptake values of the brain and liver from regions of interest manually placed over the frontal cortex at the level of the centrum semiovale and the right lobe of the liver parenchyma, respectively.

RESULTS: Fasting blood glucose (FBG; odds ratio [OR] = 1.063, p < 0.001) and glycated hemoglobin (HbA1c; OR = 3.634, p = 0.010) were the strongest predictive factors for low brain FDG uptake, whereas waist circumference (OR = 1.200, p < 0.001) and γ-glutamyl transpeptidase (OR = 1.012, p = 0.001) were the strongest predictive factors for high liver uptake. Eleven subjects (4.2%) showed concurrent low brain and high liver FDG uptake, and all but one of these subjects (90.9%) had MS. Systolic blood pressure, waist circumference, FBG, triglyceride, alanine aminotransferase, insulin resistance (measured by homeostasis model assessment), insulin, HbA1c, and body mass index were higher in subjects with this FDG uptake pattern than in those without (all, p < 0.001).

CONCLUSION: Concurrent low brain and high liver FDG uptake were closely associated with MS. Moreover, subjects with this pattern had higher values for various cardiovascular risk factors than did those without.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Nam HY, Jun S, Pak K, et al. Concurrent Low Brain and High Liver Uptake on FDG PET Are Associated with Cardiovascular Risk Factors. Korean J Radiol. 2017. PMID: 28246520. doi:10.3348/kjr.2017.18.2.392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。